C.F.R. » Title 21 » CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES › SUBCHAPTER C—DRUGS: GENERAL › PART 201—LABELING › Subpart D—Exemptions From Adequate Directions for Use

21 C.F.R. § 201.125

Drugs for use in teaching, law enforcement, research, and analysis

Read at: eCFRecfr.gov CornellLII GovInfogovinfo.gov CasesGoogle Scholar

A drug subject to § 201.100 or § 201.105, shall be exempt from section 502(f)(1) of the act if shipped or sold to, or in the possession of, persons regularly and lawfully engaged in instruction in pharmacy, chemistry, or medicine not involving clinical use, or engaged in law enforcement, or in research not involving clinical use, or in chemical analysis, or physical testing, and is to be used only for such instruction, law enforcement, research, analysis, or testing.

[41 FR 6911, Feb. 13, 1976]
Notes of Decisions
Cited in 1 case, 2005–2005 · leading case: United States v. Livdahl, 459 F. Supp. 2d 1255 (S.D. Fla. 2005).
Sort: Relevance Newest Treatment
United States v. Livdahl, 459 F. Supp. 2d 1255 (S.D. Fla. 2005). “” The defendant asserts *1262 that TRI’s product is exempt from this provision pursuant to the FDA’s interpretative regulation, 21 C.F.R. § 201.125 which states that drugs which ordinarily would be subject to the labeling provisions of § 352(f)(1) are exempt from those…”
Annotations are extracted automatically from the opinions in the Syfert caselaw corpus and ranked by authority, recency, and treatment. Dots show Syfertize treatment of the citing case itself.